A detailed history of Parkside Financial Bank & Trust transactions in Inari Medical, Inc. stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 10 shares of NARI stock, worth $554. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10
Previous 10 -0.0%
Holding current value
$554
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$37.11 - $50.69 $371 - $506
10 New
10 $0
Q4 2023

Feb 01, 2024

BUY
$48.3 - $68.06 $5,119 - $7,214
106 Added 42.23%
357 $23,000
Q3 2023

Nov 13, 2023

BUY
$54.2 - $71.67 $13,604 - $17,989
251 New
251 $16,000
Q2 2022

Jul 13, 2022

SELL
$52.13 - $93.81 $2,137 - $3,846
-41 Reduced 14.86%
235 $16,000
Q1 2022

May 13, 2022

BUY
$64.92 - $99.47 $17,917 - $27,453
276 New
276 $25,000

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.96B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Parkside Financial Bank & Trust Portfolio

Follow Parkside Financial Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.